Company Filing History:
Years Active: 1984-1992
Title: Huibert C Moelker: Innovator in Antithrombotic Research
Introduction
Huibert C Moelker is a notable inventor based in Megen, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic agents. With a total of 2 patents to his name, his work has the potential to impact medical treatments significantly.
Latest Patents
Moelker's latest patents include innovations related to sulphated glycosaminoglycuronan with antithrombotic activity. The first patent describes a composition consisting of salts of dermatan sulphate, chondroitin sulphate, and heparan sulphate, characterized by its anti-thrombotic properties. The second patent presents a new anti-thromboticum based on a mixture of oligo- and polysaccharides, along with methods for its preparation. This product, derived from mammal tissue, particularly intestinal mucous, boasts a high 'benefit/risk' ratio, making it a promising candidate for therapeutic applications.
Career Highlights
Huibert C Moelker is associated with Akzo N.V., a company known for its innovative solutions in various sectors, including pharmaceuticals. His work at Akzo N.V. has allowed him to focus on developing effective treatments that address critical health issues.
Collaborations
Throughout his career, Moelker has collaborated with esteemed colleagues such as Adrianus L Sanders and Dirk Gerrit Meuleman. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.
Conclusion
Huibert C Moelker's contributions to antithrombotic research exemplify the importance of innovation in the pharmaceutical industry. His patents and collaborative efforts continue to pave the way for advancements in medical treatments.